Status:
COMPLETED
SCANCAP Scandinavian Automatic Capture Study
Lead Sponsor:
Guidant Corporation
Conditions:
Bradycardia
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this study is to document the success rate of the automatic threshold testat pre-discharge in a normal pacemaker patient population implanted with Guidant Insignia Ultra or AV...
Detailed Description
Currently the optimal programming of the pacemaker output considers both pacemaker efficiency (prolonging battery longevity) and patient safety (adequate safety margin). A decrease in the programmed o...
Eligibility Criteria
Inclusion
- Suitable candidate for a INSIGNIA I Ultra or Insignia I AVT pacemaker (with a ventricular lead). Availability for follow-up at the centre. Willingness to participate in this study. Age 18 or above, or of legal age to give informed consent as specified by national law.
Exclusion
- Inability or refusal to sign the Patient Informed Consent. Known pregnancy. Presence of mechanical tricuspid valve
Key Trial Info
Start Date :
December 1 2003
Trial Type :
OBSERVATIONAL
End Date :
July 1 2006
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT00180609
Start Date
December 1 2003
End Date
July 1 2006
Last Update
April 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicinsk Afdeling, Sygehus Viborg
Viborg, Denmark